Why Is ALPHA TAU MED LTD (DRTS) Stock Moving Today?
By the Top Tier Newswire AI Desk · reviewed against 1 wire stories
ALPHA TAU MED LTD (DRTS) is drawing unusual attention today. Our newswire has captured 1 story on DRTS across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 58/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for DRTS publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
AI sentiment, last 36h · averaged over 1 story · 58/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
1h agoMarketChameleonBULLISH 58Product/PR
DRTS highlights FDA clearance to expand REGAIN glioblastoma trial from 10 to 20 patients ahead of SNO 2026 data presentation
October 19, 2026
Alpha Tau Medical said the FDA approved an IDE supplement expanding its U.S. REGAIN recurrent glioblastoma study from 10 to 20 patients, while adding progression-free survival and quality-of-life assessments to broaden the clinical dataset. The company also announced that an updated REGAIN safety interim analysis abstract was accepted for presentation at the Society for Neuro-Oncology’s 2026 annual meeting in Philadelphia.
Frequently asked questions
Why is DRTS stock moving today?
ALPHA TAU MED LTD (DRTS) is drawing unusual attention today. Our newswire has captured 1 story on DRTS across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "DRTS highlights FDA clearance to expand REGAIN glioblastoma trial from 10 to 20 patients ahead of SNO 2026 data presentation
October 19, 2026" (MarketChameleon).
Is DRTS a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of DRTS coverage reads 58/100 over 1 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →